The acquisition aims to accelerate the development of targeted therapies for EGFR mutant NSCLC patients globally.
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 14, Reuters reported that Takeda Pharmaceutical Company Limited (NYSE:TAK) and ...
Algorithm, a pioneering regional pharmaceutical manufacturer has announced the signing of a strategic partnership agreement with Batterjee Pharma, a leading Saudi pharmaceutical company, becoming the ...
GSK is the largest pharmaceutical partner operating at Bora’s state-of-the-art Mississauga facility, where Bora provides end-to-end manufacturing services for more than 20 commercial product lines and ...
ALGIERS, Algeria and AMMAN, Jordan, Jan. 26, 2026 /PRNewswire/ -- MS Pharma Group, a leading regional pharmaceutical company in the MENA region, has signed a strategic partnership agreement with ...
The White House announced it has signed nine new agreements with pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi ...
TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier ...